| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2072 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1489 | 2018 |
| Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis AI Gomaa, SA Khan, MB Toledano, I Waked, SD Taylor-Robinson World journal of gastroenterology: WJG 14 (27), 4300, 2008 | 949 | 2008 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 558 | 2014 |
| Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission GS Cooke, I Andrieux-Meyer, TL Applegate, R Atun, JR Burry, ... The lancet Gastroenterology & hepatology 4 (2), 135-184, 2019 | 472 | 2019 |
| Historical epidemiology of hepatitis C virus (HCV) in selected countries P Bruggmann, T Berg, ALH Øvrehus, C Moreno, CE Brandão Mello, ... Journal of viral hepatitis 21, 5-33, 2014 | 411 | 2014 |
| What's in a name? Renaming ‘NAFLD’to ‘MAFLD’ Y Fouad, I Waked, S Bollipo, A Gomaa, Y Ajlouni, D Attia Liver international 40 (6), 1254-1261, 2020 | 309 | 2020 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 297 | 2022 |
| Diagnosis of hepatocellular carcinoma AI Gomaa, SA Khan, ELS Leen, I Waked, SD Taylor-Robinson World Journal of Gastroenterology: WJG 15 (11), 1301, 2009 | 274 | 2009 |
| Strategies to manage hepatitis C virus (HCV) disease burden H Wedemeyer, AS Duberg, M Buti, WM Rosenberg, S Frankova, G Esmat, ... Journal of viral hepatitis 21, 60-89, 2014 | 272 | 2014 |
| Impact of COVID-19 on global HCV elimination efforts S Blach, LA Kondili, A Aghemo, Z Cai, E Dugan, C Estes, I Gamkrelidze, ... Journal of hepatology 74 (1), 31-36, 2021 | 255 | 2021 |
| Hepatitis C in Egypt–past, present, and future A Elgharably, AI Gomaa, MME Crossey, PJ Norsworthy, I Waked, ... International journal of general medicine, 1-6, 2016 | 229 | 2016 |
| Screening and treatment program to eliminate hepatitis C in Egypt I Waked, G Esmat, A Elsharkawy, M El-Serafy, W Abdel-Razek, R Ghalab, ... New England Journal of Medicine 382 (12), 1166-1174, 2020 | 223 | 2020 |
| Hepatitis C infection in Egypt: prevalence, impact and management strategies A Gomaa, N Allam, A Elsharkway, M El Kassas, I Waked Hepatic medicine: evidence and research, 17-25, 2017 | 209 | 2017 |
| National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care W El‐Akel, MH El‐Sayed, M El Kassas, M El‐Serafy, M Khairy, K Elsaeed, ... Journal of viral hepatitis 24 (4), 262-267, 2017 | 200 | 2017 |
| Role of hepatitis C infection in chronic liver disease in Egypt. GT Strickland, H Elhefni, T Salman, I Waked, M Abdel-Hamid, NN Mikhail, ... The American journal of tropical medicine and hygiene 67 (4), 436-442, 2002 | 177 | 2002 |
| Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study C Hézode, GM Hirschfield, W Ghesquiere, W Sievert, M Rodriguez-Torres, ... Gut 64 (6), 948-956, 2015 | 159 | 2015 |
| Hepatitis C treatment: where are we now? NJ Burstow, Z Mohamed, AI Gomaa, MW Sonderup, NA Cook, I Waked, ... International journal of general medicine, 39-52, 2017 | 154 | 2017 |
| The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? JV Lazarus, HE Mark, M Villota-Rivas, A Palayew, P Carrieri, M Colombo, ... Journal of hepatology 76 (4), 771-780, 2022 | 150 | 2022 |
| Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa G Shiha, K Alswat, M Al Khatry, AI Sharara, N Örmeci, I Waked, ... The lancet Gastroenterology & hepatology 6 (1), 57-64, 2021 | 138 | 2021 |
